or Try an Advanced Search...

    Qiagen Stocks List

    Symbol Grade Name % Change
    QGEN D Qiagen N.V. -1.39
    FLGT F Fulgent Genetics, Inc. -3.86
    View As Page of Charts
    Related Industries: Diagnostics & Research
    Related Stock Lists: Biotechnology Molecular Diagnostics Acid Algorithms Applied Genetics Biology Cancer Cardiovascular Disease Cloning Companion Diagnostic Consumable Products DNA Sequencing Food Safety Forensics Genetic Testing Genetics Genome HPV Instrumentation Systems Lab Testing

    Related ETFs - A few ETFs which own one or more of the above listed Qiagen stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 4.73
    EDOC B Global X Telemedicine & Digital Health ETF 4.35
    EKG A First Trust Nasdaq Lux Digital Health Solutions ETF 3.81
    HTEC B Robo Global Healthcare Technology and Innovation ETF 2.75
    PBE B PowerShares Dynamic Biotech & Genome 2.58
    View all Qiagen ETFs...
    Compare ETFs
    Compare EKG to HTEC Compare GNOM to EKG Compare GNOM to PBE

        Qiagen Stocks Recent News

        Date Stock Title
        Nov 13 QGEN QGEN Collaborates With McGill University Centre: Stock to Gain?
        Nov 12 QGEN QIAGEN collaborates with McGill University to advance microbiome research
        Nov 11 QGEN Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock
        Nov 11 FLGT Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript
        Nov 10 FLGT Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth
        Nov 10 FLGT Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations
        Nov 9 FLGT Fulgent Genetics Reports Strong Q3 2024 Results
        Nov 9 QGEN Qiagen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 9 QGEN Qiagen’s Financial Growth and Rising Debt in Q3 2024
        Nov 9 FLGT Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline
        Nov 8 QGEN Why Qiagen (QGEN) is a Top Value Stock for the Long-Term
        Nov 8 FLGT Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates
        Nov 8 FLGT Fulgent Genetics Non-GAAP EPS of $0.31 beats by $0.46, revenue of $71.74M in-line
        Nov 8 FLGT Fulgent Genetics Non-GAAP EPS of $0.31 beats by $0.46, revenue of $71.7M in-line
        Nov 8 FLGT Fulgent Reports Third Quarter 2024 Financial Results
        Nov 8 QGEN Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
        Nov 8 FLGT TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates
        Nov 7 QGEN Qiagen N.V. (QGEN) Q3 2024 Earnings Call Transcript
        Nov 7 FLGT Fulgent Genetics Q3 2024 Earnings Preview
        Nov 7 QGEN Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation?
        Related Industries: Diagnostics & Research
        Related Stock Lists: Biotechnology Molecular Diagnostics Acid Algorithms Applied Genetics Biology Cancer Cardiovascular Disease Cloning Companion Diagnostic Consumable Products DNA Sequencing Food Safety Forensics Genetic Testing Genetics Genome HPV Instrumentation Systems Lab Testing
        Qiagen

        QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. QIAGEN’s shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Peer M. Schatz is the company’s chief executive officer. The main operative headquarters are located in Hilden, Germany.

        More about Qiagen
        Browse All Tags